Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04321876 · ClinicalTrials.gov registry record
Evaluation of a Collaborative Behavioral Health Program Implementation in Primary Care
A clinical trial of Depression, sponsored by Northwestern University.
- Active
- Registry status
- 778
- Enrollment target
- 1
- Study location
NCT04321876: Active study of Depression, sponsored by Northwestern University.
NCT04321876 is a study of Depression that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 778 participants, roughly in line with the 785-participant average among 679 other Depression trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04321876, a study of Depression, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- 778 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will give researchers the opportunity to evaluate implementation of the Collaborative Behavioral Health Program (CBHP), based on the collaborative care model for depression, which aims to improve practice for physicians and staff; improve care for patients; and improve clinic operations through a model that allows for more efficient identification and referral for care for depression.
Primary Outcome
Trends in the rate at which CBHP is implemented over successive practices, as assessed by the Universal Stages of Implementation Completion (USIC)
Conditions Studied
Interventions
- BEHAVIORAL Collaborative Behavioral Health Program
Study Locations (1)
Illinois
- Northwestern Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 778 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2025-09-01 |
What the registry record for NCT04321876 still lists
NCT04321876 is an observational study that tracks outcomes without assigning an intervention. The registered 778 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 785-participant average among 679 other Depression trials with a reported enrollment target.
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Collaborative Behavioral Health Program is the first listed.
NCT04321876 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04321876 about?
NCT04321876 is a clinical study titled "Evaluation of a Collaborative Behavioral Health Program Implementation in Primary Care". This study will give researchers the opportunity to evaluate implementation of the Collaborative Behavioral Health Program (CBHP), based on the collaborative care model for depression, which aims to improve practice for physicians and staff; improve care for patients; and improve clinic operations t...
What is the current status of trial NCT04321876?
This trial is currently active not recruiting. The enrollment target is 778 participants. The study started on 2018-09-01. Estimated completion is 2025-09-01.
What conditions does trial NCT04321876 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT04321876?
The interventions under investigation include: Collaborative Behavioral Health Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04321876?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04321876 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04321876's enrollment target sits among peer trials
778 54th of 679 higher than 626 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06841679 · 778 participants · Phase 2
Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT05642611 · 777 participants · Phase 3
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
- NCT05046613 · 780 participants
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- NCT05100862 · 780 participants · Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy